Document is current
Any future updates will be listed below
-
Authors
Krychtiuk, Konstantin A.
Granger, Christopher B.
Gersh, Bernard J. https://orcid.org/0000-0001-5605-900X
- License Information
-
More Information
Article History
First Online: 12 February 2025
Competing interests
: K.A.K. is on the advisory board of Amarin and Sanofi; has received speaker fees from Amarin, Daichii Sankyo and Zoll Medical; and has received travel support funding from Amgen and Daiichi Sankyo. C.B.G. has received consulting fees from AbbVie, Abiomed, Alnylam, Anthos, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardionomic, Celecor Therapeutics, Hengrui USA, Janssen, Medscape, Medtronic, Merck, NephroSynergy, Novo Nordisk, NIH, Novartis, Pfizer, Philips and REATA; has grants or contracts with Boehringer Ingelheim, Bristol Myers Squibb, the FDA, Janssen, Lilly, Novartis, Pfizer, Philips; and has equity in Tenac.io. B.J.G. is on the advisory board of Caristo Diagnostics.
